William E. Ford - Jun 25, 2021 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for William E. Ford
Stock symbol
RPRX
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/29/2021, 08:29 PM
Previous filing
Jun 17, 2021
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +5.73K $0.00 5.73K Jun 25, 2021 Direct F1
holding RPRX Class A Ordinary Shares 540K Jun 25, 2021 By Groton Restricted Fund LP F2
holding RPRX Class A Ordinary Shares 1.5M Jun 25, 2021 GA RP Holding, L.P. F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
F2 The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. MPC maintains an investment as a limited partner of Groton Restricted Fund LP. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein.
F3 The Reporting Person is employed by an entity affiliated with GA RP Holding, L.P. ("GA RP Holding"). The limited partners of GA RP Holding that share beneficial ownership of the ordinary shares held by GA RP Holding are GAP Coinvestments CDA, L.P. ("GAPCO CDA"), GAP Coinvestments III, LLC ("GAPCO III"), GAP Coinvestments IV, L.P. ("GAPCO IV"), GAP Coinvestments V, LLC ("GAPCO V"), General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU") and General Atlantic Partners (Lux), SCSp ("GAP Lux").
F4 GA RP Holding, Ltd. ("GA RP Ltd.") is the general partner of GA RP Holding. General Atlantic LLC ("GA LLC") is the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. General Atlantic GenPar (Lux), SCSp ("GA GenPar Lux") is the general partner of GAP Lux, and General Atlantic (Lux) S.a.r.l ("GA Lux Sarl") is the general partner of GA GenPar Lux. General Atlantic GenPar (Bermuda), L.P. ("GA GenPar Bermuda") is the sole shareholder of GA Lux Sarl, and the general partner of GAP Bermuda IV and GAP Bermuda EU. GAP (Bermuda) Limited is the general partner of GA GenPar Bermuda and the sole shareholder of GA RP Ltd.
F5 There are nine members of the management committee of GA LLC (the "GA Management Committee"), and the GA Management Committee is ultimately responsible for the management of GAP (Bermuda) Limited. The Reporting Person is a member of the GA Management Committee and is Chief Executive Officer and a Managing Director of GA LLC.
F6 GA LLC, GA GenPar Bermuda, GAP (Bermuda) Limited, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GAP Bermuda IV, GAP Bermuda EU, GAP Lux, GA RP Ltd, GA GenPar Lux and GA Lux Sarl are a "group" within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee disclaims ownership of the ordinary shares except to the extent he or she has a pecuniary interest therein.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney